Recruiting studies: Targeted Axillary Dissection Tad

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TAD After Chemotherapy in Locally Advanced Breast Cancer
Phase N/A · 2 location(s) · Hospital Universitari de Bellvitge · NCT05763641 Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07546695 Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
NA · 3 location(s) · Jewish General Hospital · NCT04671511 TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
Phase N/A · 1 location(s) · Kliniken Essen-Mitte · NCT05462457 Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
Phase N/A · 14 location(s) · European Institute of Oncology · NCT07278726

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.